We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fluorescence Microscopy Becomes Accessible to All Scientists

By LabMedica International staff writers
Posted on 04 Dec 2011
An integrated bench top instrument with an intuitive user interface enables quick detection and verification of fluorescently labeled cells without compromising image quality.

The FLoid Cell Imaging Station enables fast verification of labeled cells through an intuitive user interface at one-third the cost. More...
A high-quality image can be captured in less than five minutes and printed directly from the platform's printer or downloaded and e-mailed to serve as supporting documentation.

Traditional fluorescent microscopes have historically been cumbersome to use. The set up time alone for some often takes more than 30 minutes, and they need experienced technicians to run them Instead of conveniently stationing them on bench tops, each typically must be placed in a darkroom, which takes up space that could be used for other purposes.

Depending on the specific cellular structure or biological activity users are interested in capturing, the preloaded reference tool provides the precise protocol to follow and reagents to use for optimal performance on the instrument.

Life Technologies Corporation (Grand Island, NY, USA) launched the FLoid Cell Imaging Station, a platform that eliminates the complexity of fluorescence microscopy, making it accessible to scientists, regardless of their technical expertise.

Related Links:

Life Technologies Corporation


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The method that profiles DNA methylation in cell-free DNA from a single blood sample to detect disease signals system-wide (photo courtesy of Shutterstock)

cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

Early, accurate detection of cancer and organ disease remains limited by cost, reliance on targeted mutation assays, and uncertainty about the signal’s tissue of origin. Many liquid biopsy approaches require... Read more

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

Pathology

view channel
Image: Spatial characterization of immune–tumor interactions and treatment response across SCLC and extended phenotype models (Cristian Barrera et al, npj Precision Oncology (2026). DOI: 10.1038/s41698-025-01225-9)

AI Pathology Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.